Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Zhi-Dong Wang"'
Autor:
Xiao-Hui Zhang, Huan Chen, Lan-Ping Xu, Wei Han, Zhi-Dong Wang, Xiao-Dong Mo, Xiao-Jun Huang, Fei-Fei Tang, Yue-Wen Wang, Yu Wang, Yu-Qian Sun, Feng-Rong Wang, Yan-Rong Liu, Ying-Jun Chang, Ya-Zhe Wang, Yu-Hong Chen, Kai-Yan Liu, Chen-Hua Yan
Publikováno v:
Current Medical Science. 41:443-453
SummaryWe performed a retrospective analysis to investigate dynamic peri-hematopoietic stem cell transplantation (HSCT) minimal/measurable residual disease (MRD) on outcomes in patients with T-cell acute lymphoblastic leukemia (T-ALL). A total of 271
Publikováno v:
Alimentary pharmacologytherapeuticsREFERENCES. 55(10)
Autor:
Jun Kong, Ting-Ting Han, Xiao-Hui Zhang, Xiao-Jun Huang, Xiao-Su Zhao, Yi-Fei Cheng, Zhi-Dong Wang, Yi-Ning Zhang, Yu-Qian Sun, Lan-Ping Xu, Feng-Rong Wang, Yu Wang, Chen-Hua Yan, Kai-Yan Liu
Publikováno v:
Transplant Infectious Disease. 23
BACKGROUND Human herpesvirus 6 (HHV-6) reactivation is relatively common after allogeneic hematopoietic stem cell transplantation (allo-HSCT). However, the incidence of HHV-6 reactivation and the clinical outcomes following unmanipulated haploidentic
Autor:
Feng-Rong Wang, Lan-Ping Xu, Ting-Ting Han, Chen-Hua Yan, Le-Qing Cao, Yu-Hong Chen, Xiao-Jun Huang, Jun Kong, Yu-Qian Sun, Ying-Jun Chang, Huan Chen, Xiao-Hui Zhang, Wei Han, Yao Chen, Jing-Rui Zhou, Kai-Yan Liu, Xiao-Dong Mo, Yi-Fei Cheng, Xiao-Su Zhao, Zhi-Dong Wang, Jing-Zhi Wang, Yuan-Yuan Zhang, Yu Wang
Publikováno v:
Transplantation and Cellular Therapy. 27:870.e1-870.e7
Late-onset severe pneumonia (LOSP) is defined as severe pneumonia developing during the late phase of allogeneic hematopoietic stem cell transplantation (allo-HSCT). Because of the high mortality in patients with LOSP, it is important to identify pro
Autor:
Xiao-Li Zheng, Zhi-Dong Wang, Jing Liu, Hengxiang Wang, Mei Xue, Li Ding, Dong-Mei Han, Hong-Min Yan, Ling Zhu
Publikováno v:
International journal of hematology. 106(6)
In the present study, we sought to analyze the risk factors following haploidentical hematopoietic stem cell transplantation (haplo-HSCT) in children with high-risk acute leukemia. We retrospectively reviewed data from 73 children with high-risk leuk
Autor:
Lan Dong, Yi-Qun Zhan, Chang-Yan Li, Rui-Yun Peng, Wei Li, Miao Yu, Fan Yang, Ya-Bing Gao, Chang-Hui Ge, Qing-Ming Wang, Wang-Xiang Xu, Chuan-Zeng Cao, Zhi-Dong Wang, Meng-Meng Cao, Xiao-Ming Yang
Publikováno v:
Gut. 59:817-826
Human hepassocin (HPS) was originally detected by subtractive and differential cDNA cloning as a liver-specific gene that was markedly upregulated during liver regeneration. Previous studies suggested that HPS showed mitogenic activity on isolated he
Autor:
Lian-Ning Duan, Hong-Min Yan, Mei Xue, Zi-Kuan Guo, Jing Liu, Zhi-Dong Wang, Ling Zhu, Heng-Xiang Wang
Publikováno v:
Leukemia & Lymphoma. 50:1488-1493
Here, we report the preliminary results of haploidentical hematopoietic stem cell transplantation (Haplo-HSCT) with granulocyte-colony-stimulating factor (G-CSF) mobilized bone marrow grafts without T-cell depletion for 10 patients with refractory no
Autor:
Dong-Mei Han, Hong-Min Yan, Zi-Kuan Guo, Li Ding, Zhi-Dong Wang, Heng-Xiang Wang, Ling Zhu, Xiao-Li Zheng
Publikováno v:
Leukemialymphoma. 56(5)
In this study, 25 children with high-risk acute leukemia received haploidentical hematopoietic stem cell transplant (haplo-HSCT) with co-transfusion of umbilical cord multipotent mesenchymal cells (UC-MSCs). Adverse effects, hematopoietic recovery, c
Autor:
Chun Long Li, Peng Cheng Kang, Xing Ming Jiang, Yun Fu Cui, Xiang Yu Zhong, Sheng Tai, Zhi Dong Wang, Ming Wan
Publikováno v:
Pancreatology. 16:S28
Objective: To investigate the clinical application of binding pancreaticogastrostomy (BPG) anastomosis in medial pancreatectomy(MP). Methods: The clinical data of 62 patients with benign and low-grade malignant lesions in neck and body of pancreas wh
Publikováno v:
Blood. 116:3552-3552
Abstract 3552 Introduction: Haploidentical Hematopoietic stem cell transplantation (Haplo-HSCT) has provided an alternative option since virtually all patients have an immediately available donor. In order to reduce the occurrence of severe acute GVH